Curing Death
  Recent News |  Archives |  Tags |  About |  Newsletter |  Submit News |  Advertise With Us |  Subscribe to CuringDeath.com RSS Fee Subscribe
New Articles
Selenium may slow march of AIDS 12/3/2008

Where does the gene activity of youth go? New findings may hold the key 12/3/2008

Researchers identify genomic causes of a certain type of leukemia relapse 12/2/2008

Master gene plays key role in blood sugar levels 12/2/2008

Researchers recreate SARS virus, open door for potential defenses against future strains 12/2/2008

Scientists discover 21st century plague 12/2/2008

Researchers identify potential new drug target for chronic leukemia 12/1/2008

Radiation before surgery improves pancreatic cancer outcomes 12/1/2008

Scientists show how a protein that determines cell polarity prevents breast cancer 11/30/2008

Researchers identify novel approach for suppressing prostate cancer development 11/30/2008

Genomic signature of colon cancer may individualize treatment 11/29/2008

Cancer cell 'bodyguard' turned into killer 11/29/2008

Vitamin K linked to insulin resistance in older men 11/29/2008

Old flies can become young moms 11/28/2008

Ants may help researchers unlock mysteries of human aging process 11/28/2008

Scientists Identify A New Mechanism In The Malaria Parasite To Help It Adapt To Infected Individuals (8/5/2007)

Tags:
malaria, parasites

The malaria parasite circulates in the the boodstream and attacks red bood cells. Once inside, will continue its life cycle.
The malaria parasite circulates in the the boodstream and attacks red bood cells. Once inside, will continue its life cycle.
Plasmodium falciparum is responsible for the most severe forms of human malaria. Invasion of host red blood cells is an essential step of the complex life cycle of this parasite. During the process of invasion, P. falciparum, which appears in the stage of a "merozoite", is exposed to antibodies from the immune system. Consequently, the proteins of the merozoite that interact with red blood cells are a possible weak point, and thus a very clear target to develop vaccines. Alfred Cortés, an ICREA researcher working at IRB Barcelona and an expert in molecular parasitology, together with researchers from the National Institute for Medical Research (NIMR) in London, have discovered that the parasite has the ability to switch on and off the expression of some of the proteins it uses to enter its victim's red blood cells. The researchers believe that this ability makes the parasite more adaptable when attempting to invade the cells. The study is published in Friday's issue of Plos Pathogens, the scientific journal with the greatest impact on the field of Parasitology.

30 genes are know to be involved in the process of invasion. Now, the scientists have found that P. falciparum can activate and deactivate the expression of 7 of these genes (and their corresponding proteins) without compromising the parasite's ability to enter normal or modified red blood cells. According to Cortés, this suggests that the varied expression of these genes may help the parasite to escape the host organism's immune responses, although the researcher points out that this is yet to be confirmed.

The researchers discovered that the silencing mechanism happens at the epigenetic level, meaning that the parasite stops expressing a certain gene without changing the underlying genetic information, and that the mechanism is flexible, adaptable and easily reversible. This means that the parasite can re-express the proteins relatively easily when infecting another individual or silence them again in a different host, explains Cortés. "We are talking about a very sophisticated adaptation system to the host and our challenge is to find out how this mechanism works at molecular level; that is, we need to figure out which specific epigenetic modifications are associated to activity or to silencing". Another immediate objective is to find out how many of the 30 genes involved in the invasion of red blood cells are active or inactive in parasites found in nature. "Thanks to this study we have been able to identify 7 genes in 4 different genetic families that may be silenced in a specific P. falciparum strain; we suspect, however, that other genes may also be silenced, and we'll follow this up with studies on wild strains of the parasite", concludes Cortés.

The scientist, who leads a research line in molecular parasitology in the Genetic Translation Laboratory at IRB Barcelona, emphasises that this study has also revealed that none of these proteins acting on its own would be a suitable candidate to develop a vaccine because the parasite will still succeed in invading the red blood cell to continue its life cycle". Researchers like Alfred Cortés believe that more insight into the biology of this parasite will allow us to design vaccines with a high likelihood of success.

Note: This story has been adapted from a news release issued by IRB Barcelona

Loans - Loans - Mobile Phones - Internet Marketing

Post Comments:

Search

  Archives |  Submit News |  Advertise With Us |  Contact Us |  Links
All contents © 2000 - 2009 Web Doodle, LLC. All rights reserved.
Web Doodle, LLC does not provide medical advice, diagnosis or treatment. Please read our disclaimer